QA: Repare Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001808158_2021_Repare_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAndComprehensiveIncomeLoss'}

Graph

Absolute values for 0001808158, Repare Therapeutics Inc

  xvar xval
0 AssetsCurrent 346,552,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,948,000
3 remainder_Assets 6,586,000
4 LiabilitiesCurrent 11,014,000
5 LiabilitiesNoncurrent 59,242,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,346,000
9 ResearchAndDevelopmentExpense 40,091,000
10 remainder_Expenses -1,325,000
11 remainder_Revenues 0
12 remainder_NetIncome -305,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 357,086,000
1 Liabilities 70,256,000
2 Expenses 53,112,000
3 Revenues 0
4 StockholdersEquity 286,830,000
5 NetIncome -53,417,000
6 ComprehensiveNetIncome -53,417,000
7 BaseVar 240,379,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.68
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution